Inside Medicine
Subscribe
Sign in
Share this discussion
Covid rebound isn’t rare, and Paxlovid remains the lead suspect.
insidemedicine.substack.com
Copy link
Facebook
Email
Note
Other
Covid rebound isn’t rare, and Paxlovid…
Jeremy Faust, MD
Aug 25, 2022
Share this post
Covid rebound isn’t rare, and Paxlovid remains the lead suspect.
insidemedicine.substack.com
Copy link
Facebook
Email
Note
Other
On the asymmetry of anecdotes and the race for data.
Read →
0 Comments
Share
Share
Copy link
Facebook
Email
Note
Other
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Covid rebound isn’t rare, and Paxlovid remains the lead suspect.
Covid rebound isn’t rare, and Paxlovid…
Covid rebound isn’t rare, and Paxlovid remains the lead suspect.
On the asymmetry of anecdotes and the race for data.